ISPCHIGH SIGNALFINANCIAL10-K

ISPC underwent a dramatic 79% revenue collapse from $9.3M to $1.9M while simultaneously experiencing a massive 1,089% increase in outstanding shares from 2.5M to 29.7M shares, indicating severe operational distress and significant shareholder dilution.

The combination of collapsing revenue and extreme share dilution suggests ISPC faced a liquidity crisis requiring emergency equity financing at highly unfavorable terms. The 1,089% increase in shares outstanding will severely dilute existing shareholders' ownership, while the 79% revenue decline indicates fundamental business deterioration that threatens the company's viability.

Comparing 2026-04-01 vs 2025-04-14View on EDGAR →
FINANCIAL ANALYSIS

While ISPC's cash position improved from $1.9M to $6.9M and operating losses narrowed from -$12.7M to -$9.0M, these improvements came at the devastating cost of massive shareholder dilution through what appears to be distressed equity financing. The 79% revenue collapse and 97% decline in accounts receivable signal severe operational problems, while the dramatic increase in share count from 2.5M to 29.7M shares represents one of the most extreme dilution events possible. Despite some cost-cutting progress, the overall financial picture reveals a company in crisis mode that has sacrificed shareholder value to maintain liquidity.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+266.3%
$1.9M$6.9M

Cash position surged 266.3% — strong cash generation or capital raise providing significant financial cushion.

Capital Expenditure
Cash Flow
-98.6%
$32K454

Capex reduced 98.6% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Accounts Receivable
Balance Sheet
-96.7%
$1.4M$48K

Receivables declined — improved collection efficiency or conservative revenue recognition.

Current Assets
Balance Sheet
+93.8%
$3.6M$7.0M

Current assets grew 93.8% — improving short-term liquidity or inventory/receivables build.

Interest Expense
P&L
-93.3%
$239K$16K

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Revenue
P&L
-79.2%
$9.3M$1.9M

Revenue declined 79.2% — significant demand weakness or market share loss warrants investigation.

Operating Cash Flow
Cash Flow
+48.7%
-$8.3M-$4.2M

Operating cash flow surged 48.7% — exceptional cash generation, highest quality earnings signal.

Operating Income
P&L
+29.5%
-$12.7M-$9.0M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Net Income
P&L
+16.1%
-$12.5M-$10.5M

Net income grew 16.1% — bottom-line growth signals improving overall business health.

LANGUAGE CHANGES
NEW — 2026-04-01
PRIOR — 2025-04-14
ADDED
As of April 1, 2026, there were 29,662,250 shares of common stock, par value $0.0001 per share, of the registrant issued and outstanding.
Each reference to a fiscal year in this Annual Report refers to the fiscal year ending in the calendar year indicated (for example, fiscal 2025 refers to the fiscal year ended December 31, 2025).
Our Technology Technology Components The legacy iSpecimen Marketplace has been operational for many years as an external-facing platform designed to facilitate search and matching between researchers and suppliers.
While it supported the Company s growth and market presence, its architecture led to increasing operational complexity and fragmentation across commercial, data, and fulfillment processes.
Recently, the Company made a strategic investment in a new technology platform built on its SalesStack solution to modernize the legacy system.
+7 more — sign up free →
REMOVED
Shares of common stock held by executive officer and director and by each stockholder affiliated with a director or an executive officer have been excluded from this calculation because such persons may be deemed to be affiliates.
This determination of affiliate status is not necessarily a conclusive determination for other purposes.
As of April 14, 2025, there were 2,496,858 shares of common stock, par value $0.0001 per share, of the registrant issued and outstanding.
Each reference to a fiscal year in this Annual Report refers to the fiscal year ending in the calendar year indicated (for example, fiscal 2024 refers to the fiscal year ended December 31, 2024).
As of December 31, 2024, we had more than 7,925 external registered users on the iSpecimen Marketplace platform, representing more than 3,006 unique internet domains.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →